EU Slaps US Pharma: Pay Tariffs Or Swallow Pills Harder
Photo by Kaptured by Kasia on Unsplash
In a masterstroke of diplomatic irony, the European Union’s new trade deal might cost US pharmaceuticals between $13 and $19 billion as their "branded medicines become subject to a tariff of 15%," analysts grimly noted on Monday. Despite exporting the largest share of medicines to America—about 60% of all pharma imports—Europe’s latest move feels like charging admission before giving the aspirin. As the article put it, "Medicines are the largest European exports to the U.S. by value," which is rich, considering the US now pays extra just to get these pricey pills past customs.
Share the Story
(1 of 3)
Swipe to navigate
Source: Feeds | Published: 7/28/2025 | Author: Reuters
More Articles in Business
Politico Announces Australia Launch for 2026, Because Why Not Start Late?
Theguardian
Trump Promises Retirement Plan That Matches Generosity of Federal Workers’ Excuses
Axios
Trump Calls Supreme Court 'Unfortunate,' Then Hits Economy with ‘Better’ 10% Global Tariff
Businessinsider
Workday CEO Wonders Who to Replace with AI Before Deciding to Lay Off 400 Humans
Businessinsider
David Ellison’s 10th WBD Offer: Slightly Better Than Doing Nothing
Businessinsider
AI Slaps White-Collar Jobs, Blue-Collars Brace for Gig Economy Chain Reaction
Businessinsider
Costco, Toyota & FedEx Sue Trump For Tariff Refunds Like It’s Black Friday Cashback
Businessinsider
Lamborghini Cancels Silent EV, Citing Absence of Vroom-Feelz
Businessinsider
OpenAI Board Chair Bans AI, Demands Handwritten Genius for Meeting Prep
Businessinsider